CUREVAC NV revenue breakdown overview

CUREVAC NV revenue for the last year amounted to 535.20 M EUR, the most of which — 559.20 M EUR — came from its highest performing source at the moment, Transformative Medicines, the year earlier bringing 52.66 M EUR. The greatest contribution to the revenue figure was made by Belgium — last year it brought CUREVAC NV 543.19 M EUR, and the year before that — 46.16 M EUR.